Novartis (NVS) Superinvestor holders
32 of the superinvestors we track hold Novartis (NVS) in their latest 13F filings, $5.4B in total.
Summary
The largest holder is Ken Fisher (Fisher Investments), with $2.4B, 0.7% of the portfolio.
In their latest quarter: 4 opened a new position, 11 added, 14 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ken Fisher Fisher Investments |
Added | 16,762,528 | $2.4B | 0.7% | Q3 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 6,592,124 | $1.0B | 0.6% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 5,239,309 | $821M | 1.0% | Q2 2026 |
| WCM Investment Management | Added | 1,904,349 | $300M | 0.5% | Q2 2026 |
| Brandon Haley Holocene Advisors |
New position | 1,037,332 | $163M | 0.4% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 788,033 | $124M | 0.2% | Q2 2026 |
| Dodge & Cox | Trimmed | 759,373 | $119M | 0.1% | Q2 2026 |
| Harding Loevner | Trimmed | 578,234 | $90M | 0.9% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
New position | 363,000 | $57M | 0.3% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 330,061 | $52M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 281,210 | $44M | 0.0% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 245,957 | $39M | 0.1% | Q2 2026 |
| Charles Brandes Brandes Investment Partners, LP |
Added | 197,593 | $31M | 0.2% | Q2 2026 |
| Arrowstreet Capital | Added | 116,598 | $18M | 0.0% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 106,157 | $17M | 0.0% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
New position | 86,909 | $14M | 0.3% | Q2 2026 |
| Tweedy, Browne Tweedy, Browne Company |
New position | 69,009 | $10M | 0.8% | Q3 2026 |
| Mark Donovan Boston Partners |
Trimmed | 53,689 | $8M | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 50,123 | $8M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 30,125 | $5M | 0.0% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 28,162 | $4M | 0.0% | Q2 2026 |
| Lee Ainslie Maverick Capital |
Added | 27,789 | $4M | 0.0% | Q2 2026 |
| Ric Dillon Diamond Hill Capital Management |
Held | 24,822 | $4M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 18,799 | $3M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 13,992 | $2M | 0.0% | Q2 2026 |
| Thomas Kahn Kahn Brothers Group |
Trimmed | 13,186 | $2M | 0.3% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 10,588 | $2M | 0.0% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Held | 4,114 | $644,746 | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Held | 2,683 | $420,480 | 0.0% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 2,086 | $326,996 | 0.0% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Added | 1,917 | $300,432 | 0.0% | Q2 2026 |
| Sarah Ketterer Causeway Capital Management |
Added | 1,501 | $235,168 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 31 |
| Q1 2026 | 29 |
| Q4 2025 | 29 |
| Q3 2025 | 29 |
| Q2 2025 | 28 |
| Q1 2025 | 26 |
| Q4 2024 | 25 |
| Q3 2024 | 24 |
Questions about Novartis
Which superinvestors own Novartis?
32 of the superinvestors we track hold Novartis (NVS) in their latest 13F filings, $5.4B in total. Ken Fisher, PRIMECAP Management, Aziz Hamzaogullari, WCM Investment Management, Brandon Haley, Jim Simons.
Who is the largest superinvestor holder of NVS?
The largest holder is Ken Fisher (Fisher Investments), with $2.4B, 0.7% of the portfolio.
From Novartis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.